AAAAAA
Results:
1-7
|
Results: 7
Authors:
Marastoni, M
Bazzaro, M
Salvadori, S
Bortolotti, F
Tomatis, R
Citation: M. Marastoni et al., HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure, BIO MED CH, 9(4), 2001, pp. 939-945
Authors:
Marastoni, M
Bazzaro, M
Micheletti, F
Gavioli, R
Tomatis, R
Citation: M. Marastoni et al., Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: Synthesis and immunological activity, J MED CHEM, 44(14), 2001, pp. 2370-2373
Authors:
Marastoni, M
Bazzaro, M
Gavioli, R
Micheletti, F
Traniello, S
Tomatis, R
Citation: M. Marastoni et al., Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope, EUR J MED C, 35(6), 2000, pp. 593-598
Authors:
Marastoni, M
Bazzaro, M
Bortolotti, F
Tomatis, R
Citation: M. Marastoni et al., Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors, ARZNEI-FOR, 50(6), 2000, pp. 564-568
Authors:
Marastoni, M
Bazzaro, M
Bortolotti, F
Salvadori, S
Tematis, R
Citation: M. Marastoni et al., Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes, EUR J MED C, 34(7-8), 1999, pp. 651-657
Authors:
Micheletti, F
Bazzaro, M
Canella, A
Marastoni, M
Traniello, S
Gavioli, R
Citation: F. Micheletti et al., The lifespan of major histocompatibility complex class I peptide complexesdetermines the efficiency of cytotoxic T-lymphocyte responses, IMMUNOLOGY, 96(3), 1999, pp. 411-415
Authors:
Micheletti, F
Guerrini, R
Formentin, A
Canella, A
Marastoni, M
Bazzaro, M
Tomatis, R
Traniello, S
Gavioli, R
Citation: F. Micheletti et al., Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies, EUR J IMMUN, 29(8), 1999, pp. 2579-2589
Risultati:
1-7
|